Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Should antidepressants be used for major depressive disorder?
Janus Christian Jakobsen, Christian Gluud, Irving Kirsch
BMJ evidence-based medicine (2019) Vol. 25, Iss. 4, pp. 130-130
Open Access | Times Cited: 127

Showing 1-25 of 127 citing articles:

Association between cardiometabolic index and depression: National Health and Nutrition Examination Survey (NHANES) 2011–2014
Xiang Zhou, XiaoLiang Tao, Li Zhang, et al.
Journal of Affective Disorders (2024) Vol. 351, pp. 939-947
Closed Access | Times Cited: 26
Is There an App for That?: Ethical Issues in the Digital Mental Health Response to COVID-19
Joshua August Skorburg, Josephine Yam
AJOB Neuroscience (2021) Vol. 13, Iss. 3, pp. 177-190
Open Access | Times Cited: 57
Comparative effectiveness of exercise, antidepressants and their combination in treating non-severe depression: a systematic review and network meta-analysis of randomised controlled trials
Francesco Recchia, Chit K. Leung, Edwin C. Chin, et al.
British Journal of Sports Medicine (2022) Vol. 56, Iss. 23, pp. 1375-1380
Open Access | Times Cited: 56
Effects of Naturalistic Psychedelic Use on Depression, Anxiety, and Well-Being: Associations With Patterns of Use, Reported Harms, and Transformative Mental States
Charles L. Raison, Rakesh K. Jain, Andrew Penn, et al.
Frontiers in Psychiatry (2022) Vol. 13
Open Access | Times Cited: 46
Orbitofrontal cortex-hippocampus potentiation mediates relief for depression: A randomized double-blind trial and TMS-EEG study
Sizhu Han, Xingxing Li, Shuochi Wei, et al.
Cell Reports Medicine (2023) Vol. 4, Iss. 6, pp. 101060-101060
Open Access | Times Cited: 39
Beneficial and harmful effects of tricyclic antidepressants for adults with major depressive disorder: a systematic review with meta-analysis and trial sequential analysis
Caroline Kamp Jørgensen, Johanne Juul Petersen, Pascal Faltermeier, et al.
BMJ Mental Health (2024) Vol. 27, Iss. 1, pp. e300730-e300730
Open Access | Times Cited: 9
Probiotics for adults with major depressive disorder compared with antidepressants: a systematic review and network meta-analysis
Shilin Zhao, Suisha Liang, Jun Tao, et al.
Nutrition Reviews (2024)
Closed Access | Times Cited: 8
The risks of adverse events with mirtazapine for adults with major depressive disorder: a systematic review with meta-analysis and trial sequential analysis
Caroline Kamp Jørgensen, Johanne Juul Petersen, Pascal Faltermeier, et al.
BMC Psychiatry (2025) Vol. 25, Iss. 1
Open Access | Times Cited: 1
Effect of combination therapy of methylfolate with antidepressants in patients with depressive disorder
Afifa Siddique, Muhammad Masood Khokhar, Akbar Waheed, et al.
BMC Pharmacology and Toxicology (2025) Vol. 26, Iss. 1
Open Access | Times Cited: 1
The ‘patient voice’: patients who experience antidepressant withdrawal symptoms are often dismissed, or misdiagnosed with relapse, or a new medical condition
Anne Guy, Marion Brown, Stevie Lewis, et al.
Therapeutic Advances in Psychopharmacology (2020) Vol. 10
Open Access | Times Cited: 59
Estimates of the minimal important difference to evaluate the clinical significance of antidepressants in the acute treatment of moderate-to-severe depression
Michael P. Hengartner, Martin Plöderl
BMJ evidence-based medicine (2021) Vol. 27, Iss. 2, pp. 69-73
Closed Access | Times Cited: 55
Psychological mechanisms and functions of 5-HT and SSRIs in potential therapeutic change: Lessons from the serotonergic modulation of action selection, learning, affect, and social cognition
Clark Roberts, Barbara J. Sahakian, Trevor W. Robbins
Neuroscience & Biobehavioral Reviews (2020) Vol. 119, pp. 138-167
Closed Access | Times Cited: 53
Esmethadone-HCl (REL-1017): a promising rapid antidepressant
Maurizio Fava, Stephen M. Stahl, Sara De Martin, et al.
European Archives of Psychiatry and Clinical Neuroscience (2023) Vol. 273, Iss. 7, pp. 1463-1476
Open Access | Times Cited: 21
Pursuing personalized medicine for depression by targeting the lateral or medial prefrontal cortex with Deep TMS
Abraham Zangen, Samuel Zibman, Aron Tendler, et al.
JCI Insight (2023) Vol. 8, Iss. 4
Open Access | Times Cited: 20
Efficacy and Safety of Esmethadone (REL-1017) in Patients With Major Depressive Disorder and Inadequate Response to Standard Antidepressants
Maurizio Fava, Stephen M. Stahl, Luca Pani, et al.
The Journal of Clinical Psychiatry (2024) Vol. 85, Iss. 3
Open Access | Times Cited: 6
Is the chemical imbalance an ‘urban legend’? An exploration of the status of the serotonin theory of depression in the scientific literature
Benjamin Ang, Mark Horowitz, Joanna Moncrieff
SSM - Mental Health (2022) Vol. 2, pp. 100098-100098
Open Access | Times Cited: 24
Sex and hormonal status influence the anxiolytic-like effect of oxytocin in mice
Khalin E. Nisbett, Luis Antonio Pérez González, Marina Teruel, et al.
Neurobiology of Stress (2023) Vol. 26, pp. 100567-100567
Open Access | Times Cited: 14
Difficult lives explain depression better than broken brains
Joanna Moncrieff, Ruth Cooper, Tom Stockmann, et al.
Molecular Psychiatry (2024) Vol. 29, Iss. 1, pp. 206-209
Open Access | Times Cited: 5
A real-world analysis of antidepressant medications in US veterans aged 60 years and older: a comparative analysis
Ryan D. Pittman, S. Scott Sutton, Joseph Magagnoli, et al.
Journal of Comparative Effectiveness Research (2025) Vol. 14, Iss. 2
Closed Access
Using illicit drugs alone in Vancouver, Canada: a gender-based analysis
Kat Gallant, Kanna Hayashi, Eric C. Sayre, et al.
Substance Abuse Treatment Prevention and Policy (2025) Vol. 20, Iss. 1
Open Access
Effect of an Innovative Online Ayurveda Program for Detox and Lifestyle on Mental and Physical Health in Home-Based Adults: A Pilot Study
Viktoria Luhaste, Frederick Travis, Catherine A. Gorini, et al.
Journal of Integrative and Complementary Medicine (2025)
Closed Access
Case Studies

Cambridge University Press eBooks (2025), pp. 251-355
Closed Access
Patterns and Duration of Antidepressant Use in Australian Women: Findings From the Australian Longitudinal Study on Women’s Health
Edgar Poon, Maria Donald, Mieke L van Driel, et al.
Asia Pacific Journal of Public Health (2025)
Closed Access
Case Study: Antidepressant Medications

Cambridge University Press eBooks (2025), pp. 317-338
Closed Access
Examining the Long-Term Impacts of Psychotropic Drugs and Considerations for People Discontinuing Treatment
Timothy Wand
Issues in Mental Health Nursing (2025), pp. 1-9
Open Access
Page 1 - Next Page

Scroll to top